文献速递小儿眼科与斜弱视眼整形与眼眶

Fgf10/Fgfr2/Sox9模块遗传调控泪道发育中的Wnt/PCP组分

Genetic Regulation of Wnt/PCP Components Through Fgf10/Fgfr2/Sox9 Module in Tear Duct Development.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究通过Fgf10、Fgfr2或Sox9基因敲除小鼠,结合免疫组化、原位杂交、单细胞RNA测序、CUT&Tag、荧光素酶报告基因和EMSA,发现Fgf10/Fgfr2/Sox9模块遗传调控参与胚胎泪道延伸的Wnt/PCP基因亚群,且Sox9结合并激活Prickle1启动子。Fgf信号单向作用于Wnt/PCP组分,提示Wnt/PCP组分可能是先天性鼻泪管阻塞(CNLDO)的潜在风险因素。

要点

  • Fgf10和Fgfr2通过控制泪道祖细胞增殖与存活,参与泪道形成。
  • Fgf10/Fgfr2/Sox9模块遗传调控胚胎泪道延伸相关的Wnt/PCP基因亚群。
  • Sox9结合并激活Prickle1启动子,Fgf信号单向作用于Wnt/PCP组分。

核心结论

  • 本研究揭示了Fgf信号与Wnt/PCP通路在泪道形成中此前未被认识到的直接遗传联系。
  • Wnt/PCP组分可能是先天性鼻泪管阻塞(CNLDO)的潜在风险因素,值得进一步研究。

研究设计与样本

  • 研究构建了Fgf10、Fgfr2或Sox9基因破坏的突变小鼠。
  • 采用免疫组化和原位杂交结合分子标记评估泪道发育。
  • 使用单细胞RNA测序联合CUT&Tag分析定义泪道分子身份并鉴定Fgf信号通路潜在靶点。
  • 通过荧光素酶报告基因实验和电泳迁移率变动分析(EMSA)验证Sox9靶基因。

主要发现

  • Fgf10和Fgfr2通过控制泪道祖细胞的增殖和存活,为泪道形成所必需。
  • Fgf10/Fgfr2/Sox9模块遗传调控参与胚胎泪道延伸的Wnt/PCP基因亚群。
  • Sox9结合并激活Prickle1启动子,Prickle1是先前与泪道发育相关的核心Wnt/PCP组分。
  • Fgf信号似乎单向作用于Wnt/PCP组分,因为Prickle1突变体中Fgfr2和Sox9表达均未改变。

临床怎么用

  • 本研究为泪道发育的分子遗传机制提供新见解,提示Wnt/PCP组分可能作为CNLDO的潜在风险因素。
  • 所发现的Fgf10/Fgfr2/Sox9-Prickle1调控轴可能为未来CNLDO的遗传筛查和机制研究提供候选靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Tear duct obstruction can lead to a range of ocular surface disorders. Although Fgf signaling has been implicated in congenital tear duct obstruction, the associated signaling networks remain incompletely understood. To better elucidate the developmental biology and molecular genetics of the tear drainage system, we investigated genetic interactions between the Fgf and Wnt/planar cell polarity (PCP) pathways. METHODS: Mutant mice with disruptions of Fgf10, Fgfr2, or Sox9 were generated. Tear duct development was evaluated using immunohistochemistry and in situ hybridization with a set of molecular markers. Single-cell RNA sequencing combined with CUT&Tag analysis was used to define tear duct molecular identity and identify potential targets of the Fgf signaling pathway. A luciferase reporter assay and electrophoretic mobility shift assay (EMSA) were performed to validate Sox9 target genes. RESULTS: Fgf10 and Fgfr2 are required for tear duct formation by controlling the proliferation and survival of tear duct progenitors. The Fgf10/Fgfr2/Sox9 module genetically regulates a subset of Wnt/PCP genes involved in embryonic tear duct elongation. In particular, we show that Sox9 binds to and activates the promoter of Prickle1, a core Wnt/PCP component previously implicated in tear duct development. Finally, Fgf signaling appears to act unidirectionally on Wnt/PCP components, as neither Fgfr2 nor Sox9 expression is altered in Prickle1 mutants. CONCLUSIONS: This study uncovers a previously unrecognized direct genetic link between Fgf signaling and Wnt/PCP pathway in tear duct formation, suggesting that Wnt/PCP components may represent potential risk factors for congenital nasolacrimal duct obstruction (CNLDO), warranting further investigation.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Guo D, Zhang X, Zhao X, et al. Genetic Regulation of Wnt/PCP Components Through Fgf10/Fgfr2/Sox9 Module in Tear Duct Development. Invest Ophthalmol Vis Sci. 2026. PMID: 41823500. doi:10.1167/iovs.67.3.30

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。